Related Experiment Videos
A drug-resistant mutation in the ribosomal DNA of Tetrahymena
Abstract:
A mutation that confers resistance to the drug paromomycin is shown to be in the structural gene that codes for the ribosomal RNA in Tetrahymena. This observation was made by exploiting a variant of the ribosomal DNA that distorts amplification of this locus when a new somatic nucleus develops during conjugation. Because the allelic forms of this locus have a restriction endonuclease site polymorphism, it was possible to correlate drug resistance with presence of a specific allele. The genetic results have been confirmed by sequence analysis (presented elsewhere). Thus, the crosses presented here provide a unique opportunity to identify mutations in the ribosomal DNA.
Insights
Researchers identified a drug resistance mutation in Tetrahymena
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Drug resistance is a significant challenge in various biological systems.
- Understanding the genetic basis of drug resistance is crucial for developing effective treatments.
Purpose of the Study:
- To identify the specific gene responsible for paromomycin resistance in Tetrahymena.
- To investigate the role of ribosomal RNA genes in conferring drug resistance.
Main Methods:
- Utilized a Tetrahymena variant with altered ribosomal DNA amplification during nuclear development.
- Employed restriction endonuclease site polymorphism to track specific alleles.
- Correlated drug resistance phenotype with the presence of a particular ribosomal DNA allele.
Main Results:
- A mutation conferring paromomycin resistance was localized to the structural gene for ribosomal RNA in Tetrahymena.
- Demonstrated a direct correlation between drug resistance and a specific ribosomal DNA allele.
Conclusions:
- The study successfully identified the ribosomal RNA gene as the site of a paromomycin resistance mutation in Tetrahymena.
- This work provides a powerful genetic system for studying mutations within ribosomal DNA.